Cargando…
Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study
Compliance with medication in persons with diabetes mellitus (DM) has been a challenge during the COVID-19 pandemic, leading to poor glycemic control and higher risk of complications. In the state of Kerala, India, 20–25% of adults have DM. Our cross-sectional study aimed to assess medication compli...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228986/ https://www.ncbi.nlm.nih.gov/pubmed/35736982 http://dx.doi.org/10.3390/tropicalmed7060104 |
_version_ | 1784734619767144448 |
---|---|
author | Jaya, Ajan Maheswaran Harries, Anthony D. Rahman, Anisur Khogali, Mohammed Chinnakali, Palanivel Gopal, Bipin |
author_facet | Jaya, Ajan Maheswaran Harries, Anthony D. Rahman, Anisur Khogali, Mohammed Chinnakali, Palanivel Gopal, Bipin |
author_sort | Jaya, Ajan Maheswaran |
collection | PubMed |
description | Compliance with medication in persons with diabetes mellitus (DM) has been a challenge during the COVID-19 pandemic, leading to poor glycemic control and higher risk of complications. In the state of Kerala, India, 20–25% of adults have DM. Our cross-sectional study aimed to assess medication compliance and factors associated with poor compliance in DM persons attending selected primary care government facilities in Kerala during the COVID-19 pandemic. Persons registered with DM for >6 months were consecutively interviewed between August and September 2021. Poor compliance was defined as answering “No” to one or more of three questions related to access and intake of medication two weeks prior to and the day before the interview. Factors independently associated with poor compliance were assessed using adjusted prevalence ratios (aPr) and 95% confidence intervals. Of the 560 DM persons included, 209 (37%) exhibited poor compliance. Factors associated with poor compliance were age 19–45 years (aPr 1.4, 1.1–1.9); inability to be blood glucose tested during the COVID-19 pandemic (aPr 3.6, 2.9–4.3); not having COVID-19 (aPr 1.4, 1.0–1.9); and being double vaccinated against COVID-19 (aPr 1.4, 1.1–2.0). Focused attention must be paid to these groups to improve medication compliance and prevent DM complications and severe COVID-19-related disease. |
format | Online Article Text |
id | pubmed-9228986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92289862022-06-25 Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study Jaya, Ajan Maheswaran Harries, Anthony D. Rahman, Anisur Khogali, Mohammed Chinnakali, Palanivel Gopal, Bipin Trop Med Infect Dis Article Compliance with medication in persons with diabetes mellitus (DM) has been a challenge during the COVID-19 pandemic, leading to poor glycemic control and higher risk of complications. In the state of Kerala, India, 20–25% of adults have DM. Our cross-sectional study aimed to assess medication compliance and factors associated with poor compliance in DM persons attending selected primary care government facilities in Kerala during the COVID-19 pandemic. Persons registered with DM for >6 months were consecutively interviewed between August and September 2021. Poor compliance was defined as answering “No” to one or more of three questions related to access and intake of medication two weeks prior to and the day before the interview. Factors independently associated with poor compliance were assessed using adjusted prevalence ratios (aPr) and 95% confidence intervals. Of the 560 DM persons included, 209 (37%) exhibited poor compliance. Factors associated with poor compliance were age 19–45 years (aPr 1.4, 1.1–1.9); inability to be blood glucose tested during the COVID-19 pandemic (aPr 3.6, 2.9–4.3); not having COVID-19 (aPr 1.4, 1.0–1.9); and being double vaccinated against COVID-19 (aPr 1.4, 1.1–2.0). Focused attention must be paid to these groups to improve medication compliance and prevent DM complications and severe COVID-19-related disease. MDPI 2022-06-14 /pmc/articles/PMC9228986/ /pubmed/35736982 http://dx.doi.org/10.3390/tropicalmed7060104 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jaya, Ajan Maheswaran Harries, Anthony D. Rahman, Anisur Khogali, Mohammed Chinnakali, Palanivel Gopal, Bipin Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study |
title | Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study |
title_full | Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study |
title_fullStr | Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study |
title_full_unstemmed | Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study |
title_short | Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study |
title_sort | compliance with medication amongst persons with diabetes mellitus during the covid-19 pandemic, kerala, india: a cross sectional study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228986/ https://www.ncbi.nlm.nih.gov/pubmed/35736982 http://dx.doi.org/10.3390/tropicalmed7060104 |
work_keys_str_mv | AT jayaajanmaheswaran compliancewithmedicationamongstpersonswithdiabetesmellitusduringthecovid19pandemickeralaindiaacrosssectionalstudy AT harriesanthonyd compliancewithmedicationamongstpersonswithdiabetesmellitusduringthecovid19pandemickeralaindiaacrosssectionalstudy AT rahmananisur compliancewithmedicationamongstpersonswithdiabetesmellitusduringthecovid19pandemickeralaindiaacrosssectionalstudy AT khogalimohammed compliancewithmedicationamongstpersonswithdiabetesmellitusduringthecovid19pandemickeralaindiaacrosssectionalstudy AT chinnakalipalanivel compliancewithmedicationamongstpersonswithdiabetesmellitusduringthecovid19pandemickeralaindiaacrosssectionalstudy AT gopalbipin compliancewithmedicationamongstpersonswithdiabetesmellitusduringthecovid19pandemickeralaindiaacrosssectionalstudy |